Will Purple Biotech Ltd - ADR (PPBT) Stay at the Top of the Healthcare Sector?

Purple Biotech Ltd - ADR (PPBT) is around the top of the Healthcare sector according to InvestorsObserver. PPBT received an overall rating of 48, which means that it scores higher than 48% of stocks. Additionally, Purple Biotech Ltd - ADR scored a 73 in the Healthcare sector, ranking it higher than 73% of stocks in that sector.

PPBT has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on PPBT!

See Full PPBT Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 48 means the stock is more attractive than 48 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Purple Biotech Ltd - ADR Stock Today?

Purple Biotech Ltd - ADR (PPBT) stock is unchanged 0% while the S&P 500 has gained 0.09% as of 10:49 AM on Tuesday, May 30. PPBT is unmoved $0.00 from the previous closing price of $1.80 on volume of 5,673 shares. Over the past year the S&P 500 has gained 1.86% while PPBT is lower by -37.50%. PPBT lost -$10.36 per share the over the last 12 months. Click Here to get the full Stock Report for Purple Biotech Ltd - ADR stock.